CLINICAL_TRIALS
trial_result
· 2017-05-01
Clinical Trial Update: Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial evaluating irinotecan and carboplatin in metastatic or recurrent small cell lung cancer completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Davis | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-05-01